maximizing Oncology study with built-in KRAS Assay products and services and RAS Assays
within the fast evolving discipline of oncology analysis, precise and economical mutation screening is important for building specific therapies. The KRAS Services here System plays a pivotal job Within this landscape by giving detailed alternatives for KRAS mutation profiling and Investigation. KRAS mutations, present in about 95% of RAS-relevant